Barclays’s ICU Medical ICUI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$599K Sell
4,636
-33,069
-88% -$4.75M ﹤0.01% 3079
2025
Q4
$5.38M Buy
37,705
+3,640
+11% +$488K ﹤0.01% 2161
2025
Q3
$4.09M Sell
34,065
-12,532
-27% -$1.59M ﹤0.01% 2353
2025
Q2
$6.16M Buy
46,597
+16,362
+54% +$2.22M ﹤0.01% 1943
2025
Q1
$4.2M Sell
30,235
-19,846
-40% -$3.08M ﹤0.01% 2050
2024
Q4
$7.77M Sell
50,081
-9,126
-15% -$1.54M ﹤0.01% 1771
2024
Q3
$10.8M Buy
59,207
+8,010
+16% +$1.19M ﹤0.01% 1434
2024
Q2
$6.08M Sell
51,197
-453
-0.9% -$47.7K ﹤0.01% 1435
2024
Q1
$5.54M Buy
51,650
+47,081
+1,030% +$4.68M ﹤0.01% 1781
2023
Q4
$456K Sell
4,569
-5,532
-55% -$541K ﹤0.01% 3935
2023
Q3
$1.2M Sell
10,101
-44,981
-82% -$6.71M ﹤0.01% 2200
2023
Q2
$9.82M Sell
55,082
-12,150
-18% -$2.23M 0.01% 999
2023
Q1
$11.1M Buy
67,232
+51,513
+328% +$8.86M 0.01% 1116
2022
Q4
$2.48M Sell
15,719
-36,185
-70% -$5.51M ﹤0.01% 2109
2022
Q3
$7.82M Buy
51,904
+48,368
+1,368% +$8.05M 0.01% 951
2022
Q2
$581K Sell
3,536
-28,402
-89% -$5.47M ﹤0.01% 2760
2022
Q1
$7.11M Buy
31,938
+25,108
+368% +$5.62M 0.01% 1060
2021
Q4
$1.62M Sell
6,830
-141,099
-95% -$33M ﹤0.01% 2507
2021
Q3
$34.5M Buy
147,929
+112,126
+313% +$23.5M 0.02% 670
2021
Q2
$7.37M Buy
35,803
+13,057
+57% +$2.69M ﹤0.01% 1355
2021
Q1
$4.67M Buy
22,746
+21,239
+1,409% +$4.49M ﹤0.01% 1575
2020
Q4
$324K Sell
1,507
-15,082
-91% -$2.93M ﹤0.01% 3507
2020
Q3
$3.03M Sell
16,589
-5,538
-25% -$1.04M ﹤0.01% 1758
2020
Q2
$4.08M Sell
22,127
-20,007
-47% -$3.97M ﹤0.01% 1528
2020
Q1
$8.5M Buy
42,134
+15,086
+56% +$2.9M 0.01% 1093
2019
Q4
$5.06M Buy
27,048
+11,520
+74% +$1.98M ﹤0.01% 1981
2019
Q3
$2.48M Buy
15,528
+9,992
+180% +$1.99M ﹤0.01% 2602
2019
Q2
$1.39M Buy
5,536
+1,673
+43% +$388K ﹤0.01% 3334
2019
Q1
$924K Sell
3,863
-27,043
-88% -$6.48M ﹤0.01% 3482
2018
Q4
$7.1M Buy
30,906
+16,568
+116% +$4.08M 0.01% 1358
2018
Q3
$4.05M Sell
14,338
-20,170
-58% -$5.91M ﹤0.01% 2030
2018
Q2
$10.1M Buy
34,508
+28,590
+483% +$7.81M 0.01% 1214
2018
Q1
$1.49M Buy
5,918
+3,143
+113% +$739K ﹤0.01% 2766
2017
Q4
$599K Buy
2,775
+2,190
+374% +$443K ﹤0.01% 3613
2017
Q3
$109K Sell
585
-2,003
-77% -$349K ﹤0.01% 4870
2017
Q2
$447K Sell
2,588
-1,196
-32% -$192K ﹤0.01% 3634
2017
Q1
$577K Buy
3,784
+2,945
+351% +$430K ﹤0.01% 3259
2016
Q4
$124K Buy
839
+281
+50% +$40.7K ﹤0.01% 4594
2016
Q3
$70K Buy
+558
New +$67.3K ﹤0.01% 4763
2016
Q1
Sell
-31,100
Closed -$3.48M 6260
2015
Q4
$3.48M Buy
31,100
+25,026
+412% +$2.77M ﹤0.01% 1567
2015
Q3
$662K Buy
6,074
+5,801
+2,125% +$621K ﹤0.01% 3107
2015
Q2
$26K Sell
273
-129
-32% -$12.1K ﹤0.01% 5520
2015
Q1
$37K Sell
402
-2,700
-87% -$236K ﹤0.01% 5480
2014
Q4
$251K Sell
3,102
-383
-11% -$29.4K ﹤0.01% 4446
2014
Q3
$224K Buy
3,485
+3,231
+1,272% +$198K ﹤0.01% 4645
2014
Q2
$15K Sell
254
-279
-52% -$16.5K ﹤0.01% 6636
2014
Q1
$31K Buy
533
+205
+63% +$12.6K ﹤0.01% 6347
2013
Q4
$20K Sell
328
-8,345
-96% -$537K ﹤0.01% 6720
2013
Q3
$581K Sell
8,673
-6,139
-41% -$438K ﹤0.01% 3942
2013
Q2
$1.07M Buy
+14,812
New +$980K ﹤0.01% 3267

Other funds holding ICUI

Barclays's ICUI Position: Q1 2026 in Review

Barclays reduced its ICU Medical (ICUI) stake by 88% in Q1 2026, selling an estimated $4.75M and leaving 4,636 shares worth $599K. The position accounts for ﹤0.01% of the portfolio, ranked #3079.

Barclays first reported a position in ICUI in Q2 2013 and has held it in 50 quarters since. The position peaked at $34.5M in Q3 2021. 275 funds tracked by Wall St. Rank hold ICUI as of Q1 2026.

  • Barclays held 4,636 shares of ICU Medical worth $599K as of Q1 2026.
  • Barclays sold 33,069 ICU Medical shares in Q1 2026, an estimated $4.75M.
  • ICU Medical made up ﹤0.01% of Barclays's portfolio in Q1 2026, its #3079 holding.
  • Barclays first reported a position in ICU Medical in Q2 2013 and has held it in 50 quarters since.
  • Barclays's ICU Medical position peaked at $34.5M in Q3 2021.
  • 275 funds tracked by Wall St. Rank held ICU Medical as of Q1 2026.

Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.